| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 11/16/2011 | EP2386567A2 Mutants of cholesterol-dependent cytolysins and uses thereof |
| 11/16/2011 | EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response |
| 11/16/2011 | EP2386319A1 Promoters exhibiting endothelial cell specificity and methods of using same |
| 11/16/2011 | EP2386314A1 Vaccines against chlamydial infection |
| 11/16/2011 | EP2386313A1 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 11/16/2011 | EP2386312A2 Intrathecal and intratumoral superantigens to treat malignant disease |
| 11/16/2011 | EP2386310A2 Methods for preserving organs and tissues |
| 11/16/2011 | EP2385983A2 Transaminase polypeptides |
| 11/16/2011 | EP2385982A2 Carbonic anhydrase polypeptides and uses thereof |
| 11/16/2011 | EP2385954A1 Complex and production process |
| 11/16/2011 | EP2385953A2 Process for regulating immune response |
| 11/16/2011 | EP2385952A1 Method for the selection of endothelial cells death inducers via netrin-1 and its applications |
| 11/16/2011 | EP2385842A1 Cna_b domain antigens in vaccines against gram positive bacteria |
| 11/16/2011 | EP2385841A1 Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22 |
| 11/16/2011 | EP2297195B1 Antibacterial peptides |
| 11/16/2011 | EP2124522B1 Putative cytokinin receptor and methods for use thereof |
| 11/16/2011 | EP2121746B1 Potent and selective mediators of cholesterol efflux |
| 11/16/2011 | EP2027152B1 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 11/16/2011 | EP1976871B1 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
| 11/16/2011 | EP1937712B1 Polynucleotides of haemophilus parasuis and its use |
| 11/16/2011 | EP1901768B1 Methods of modulating il-23 activity; related reagents |
| 11/16/2011 | EP1885751B1 Bone morphogenetic protein 6 containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof |
| 11/16/2011 | EP1883649B1 Hiv vif mutants |
| 11/16/2011 | EP1765851B1 Analog compounds of analgesic peptides derived from the venom of crotalus durissus terrificus snakes, their uses, compositions, methods of preparation and purification |
| 11/16/2011 | EP1664102B1 Isolated photoprotein mtclytin, and use thereof |
| 11/16/2011 | EP1654285B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 11/16/2011 | EP1623033B1 Process of producing a plastid-targeted protein in plant cells |
| 11/16/2011 | EP1553980B1 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer |
| 11/16/2011 | EP1019439B1 Soluble single-chain t-cell receptor proteins |
| 11/16/2011 | CN1839203B FVII or FVIIa GLA domain variants |
| 11/16/2011 | CN1820018B Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 11/16/2011 | CN1732266B Plants having modified growth characteristics and a method for making the same |
| 11/16/2011 | CN1311820B BASB027 protein and genes from i(Moraxella Catarrhalis), antigens, antibodies, and uses |
| 11/16/2011 | CN102246040A Method and device for diagnosing tuberculosis |
| 11/16/2011 | CN102245781A Method for producing riboflavin |
| 11/16/2011 | CN102245768A Gene coding for protein having the ability to enhance selenic acid reduction activity |
| 11/16/2011 | CN102245642A Conjugates of GLP-1 agonists and uses thereof |
| 11/16/2011 | CN102245636A Etoposide and doxorubicin conjugates for drug delivery |
| 11/16/2011 | CN102245635A Modified variant bowman birk protease inhibitors |
| 11/16/2011 | CN102245634A Stabilized receptor polypeptides and uses thereof |
| 11/16/2011 | CN102245633A Novel insulin analogues |
| 11/16/2011 | CN102245632A Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 11/16/2011 | CN102245631A Transducible polypeptides for modifying mitochondrial metabolism |
| 11/16/2011 | CN102245630A Polypeptides having antimicrobial activity |
| 11/16/2011 | CN102245629A Modified amyloid beta peptide |
| 11/16/2011 | CN102245628A Method for extracting hydrophobin from a solution |
| 11/16/2011 | CN102245627A Vaccine against african horse sickness virus |
| 11/16/2011 | CN102245625A Method of making biologically active alpha-beta peptides |
| 11/16/2011 | CN102245623A Single-chain antiparallel coiled coil proteins |
| 11/16/2011 | CN102242173A Extraction method for envelope protein of grouper iridovirus |
| 11/16/2011 | CN102242139A Method for improving expression amount of gene recombination enterovirus 71-type VP1 |
| 11/16/2011 | CN102242137A Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 11/16/2011 | CN102242131A Eimeria tenella apical membrane antigen 1 (AMA 1) gene and application thereof |
| 11/16/2011 | CN102242129A Optimized sequence of pseudosciaena crocea growth hormone (pcGH) gene and application of optimized sequence |
| 11/16/2011 | CN102242128A Scylla paramamosain antiviral type anti-lipopolysaccharide factor, its preparation method and application |
| 11/16/2011 | CN102242127A Preparation method of serial antibacterial peptide Alloferon-1 and application of rAlloferon-1-K |
| 11/16/2011 | CN102242126A T1R taste receptors and genes encoding same |
| 11/16/2011 | CN102242054A Totally-enclosed cell and cell factor preparation device and preparation method thereof |
| 11/16/2011 | CN102241767A Extraction method of bovine serum albumin |
| 11/16/2011 | CN102241766A Method for preparing methamidophos artificial antigen |
| 11/16/2011 | CN102241765A Production method for removing fatty acid from bovine serum albumin |
| 11/16/2011 | CN102241764A Preparation method and application of pyrene artificial immunogen PY-BSA (phosphotyrosine-conjugated bovine serum albumin) |
| 11/16/2011 | CN102241763A Continuously activated growth hormone receptor gene of fishes, and preparation method and application thereof |
| 11/16/2011 | CN102241762A Solid-phase synthesis method of artificial E selectin |
| 11/16/2011 | CN102241761A Nile tilapia cholecystokinin and coding nucleic acid thereof and application of functional octopeptide |
| 11/16/2011 | CN102241760A Inactivation method for snake venom and inactivated snake venom prepared thereby |
| 11/16/2011 | CN102241759A Bacteriostatic ferritin and preparation and application thereof |
| 11/16/2011 | CN102241758A Preparation method and medical application of cervical carcinoma associated trichina antigen antibody |
| 11/16/2011 | CN102241757A Polypeptide analogue of human osteocalcin |
| 11/16/2011 | CN102241756A High expression of tenebrio molitor antibacterial peptide TmAMP3m in escherichia coli and application of TmAMP3m |
| 11/16/2011 | CN102241755A Yield per plant associated protein and coding gene and application thereof |
| 11/16/2011 | CN102241754A Method for separating and purifying phycoerythrin from bangia fusco-purpurea |
| 11/16/2011 | CN102241753A Fluorescence labeling method for microcystins |
| 11/16/2011 | CN102241752A Protein for improving plant resistance and inducing plant defense reaction, and gene and application thereof |
| 11/16/2011 | CN102241751A Novel fungal immunomodulatory protein FIP-NHA with antineoplastic activity and gene thereof |
| 11/16/2011 | CN102241750A Genetic engineering method for producing avermectin and special bacterial strain for the method |
| 11/16/2011 | CN102241749A Solid-phase synthesis method of vMIP-II (viral macrophage inflammatory protein-II) protein |
| 11/16/2011 | CN102241748A Mycobacterium phage D29 derived PK34 polypeptide and application thereof |
| 11/16/2011 | CN102241747A Humanlike elastin and production method thereof |
| 11/16/2011 | CN102241746A Method for preparing enfuvirtide |
| 11/16/2011 | CN102241745A Polypeptide analog Tat-HA-NR2B9C, and preparation method and application thereof |
| 11/16/2011 | CN102241744A Virus infection blocker, and its drug composition and application |
| 11/16/2011 | CN102241742A Peptides and compounds that bind to a thrombopoietin receptor |
| 11/16/2011 | CN102241741A Prion protein ligands and methods of use |
| 11/16/2011 | CN102241731A Technology for rapidly preparing DNA binding protein |
| 11/16/2011 | CN102240040A Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease |
| 11/16/2011 | CN101891802B Polypeptide or derivative product for treating or preventing cancer and application thereof |
| 11/16/2011 | CN101838317B Mimic short peptide 11B of endothelial cell growth factor VEGF antigen epitope and application thereof |
| 11/16/2011 | CN101736010B Stress resistance NAC transcription factor gene derived from loosehead Chinese cabbage |
| 11/16/2011 | CN101691397B Nisin mutant protein, code gene thereof and application thereof |
| 11/16/2011 | CN101665535B Method of extracting casein from milk and coproducing cleanly lactic acid beverage |
| 11/16/2011 | CN101659700B Short peptide |
| 11/16/2011 | CN101638435B Blue-green algal virus protein N mutant, modified derivative and application thereof |
| 11/16/2011 | CN101585870B Protein related to plant heat resistance property and coding gene and application thereof |
| 11/16/2011 | CN101550183B Antibacterial peptide and construction and application thereof |
| 11/16/2011 | CN101412697B 1-amino hydantoin derivative hapten, antigen and antibody and uses thereof |
| 11/16/2011 | CN101407812B Heterologous expression and purification method for human RANTES protein having chemotaxis |
| 11/16/2011 | CN101157723B Shellfish jacket membrane collagen and method for making same |
| 11/16/2011 | CN101121753B Human serum albumin recombination fusion protein with continuous repairing function to multifarious skin cell |
| 11/16/2011 | CN101103112B Compositions and methods for short interfering nucleic acid inhibition of Nav1.8 |